bpc 157 studies in humans BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded What Is BPC-157? The Body

It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes

Whether using a 5 mg or 10 mg vial , correct preparation ensures accurate dosing for controlled studies

Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC from breastfeeding and because semaglutide injection can be considered for use during lactation, advise patients that breastfeeding is not recommended during treatment with oral semaglutide tablets

it is intended only as a diluent for injectable medications

Additionally, many claims regarding BPC-157s benefits stem from preclinical studies that do not provide sufficient evidence for human applications